Safety of Magnetic Resonance Imaging in Patients with Vascular Stents

Abstract

In recent years, developments observed in percutaneous vascular procedures and rapid increase observed in the number of operators and centers that perform this procedure has promoted the treatment of percutaneous vascular interventions, and the number of patients treated by stent implantation has considerably increased. For this reason, it has been a question met very often whether the application of magnetic resonance imaging in patients with stent placement will be safe or not. The aim of this review is to investigate safety of magnetic resonance imaging in patients with vascular stent placement in the light of recent literature data.

Keywords

• -

Vasküler Stentli Hastalarda Manyetik Rezonans Görüntüleme Güvenliği

Öz

Son yıllarda perkütan vasküler işlemlerde gözlenen gelişmeler ve bu işlemi yapan operatör ve merkez sayısında gözlenen hızlı artışlar, perkütan vasküler işlemlerle yapılan tedaviyi yaygınlaştırmış ve stent uygulanarak tedavi gören hasta sayısı oldukça arttırmıştır. Bu sebeple stent takılan hastalara manyetik rezonans görüntüleme uygulamasının güvenli olup olamayacağı çok sık karşılaşılan bir soru haline gelmiştir. Bu derlemedeki amacımız son literatür verileri ışığında stentli hastalarda manyetik rezonans görüntüleme güvenliğini irdelemektir.

Anahtar Kelimeler

• Manyetik resonans görüntüleme, stent, güvenlik

References

1. 1. Shellock FG, Crues 3rd JV. MR safety and the American College of Radiology White Paper. AJR Am J Roentgenol 2002; 178: 1349-1352.
2. 2. Formica D, Silvestri S. Biological effects of exposure to magnetic resonance imaging: an overview. Biomed Eng Online 2004; 3: 11.
3. 3. Levine GN, Gomes AS, Arai AE, Bluemke DA, Flamm SD, Kanal E, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007; 116: 2878-2891.
4. 4. Magnetic resonance diagnostic device; panel recommendation and report on petitions for magnetic resonance reclassification and codification of reclassification-FDA. Final rule. Fed Regist 1989;54:5077-8.
5. 5. Colletti PM. Size "H" oxygen cylinder: accidental MR projectile at 1.5 Tesla. J Magn Reson Imaging 2004; 19: 141-143.
6. 6. Shellock FG, Crues JV. MR procedures: biologic effects, safety, and patient care. Radiology 2004; 232: 635-652.
7. 7. Takahashi M, Uematsu H, Hatabu H. MR imaging at high magnetic fields. Eur J Radiol 2003; 46: 45-52.
8. 8. American Society for Testing and Materials (ASTM) International. ASTM F2503-05 standard practice for marking medical devices and other items for safety in the magnetic resonance environment. Available from: http://www.astm.org/DATABASE.CART/HISTORICAL/F2503 -05 Accessed:June 22, 2010.

9. 9. Hug J, Nagel E, Bornstedt A, Schnackenburg B, Oswald H, Fleck E. Coronary arterial stents: safety and artifacts during MR imaging. Radiology 2000; 216: 781-787.
10. 10. Syed MA, Carlson K, Murphy M, Ingkanisorn WP, Rhoads KL, Arai AE. Long-term safety of cardiac magnetic resonance imaging performed in the first few days after bare-metal stent implantation. J Magn Reson Imaging 2006; 24: 1056-1061.
11. 11. Friedrich MG, Strohm O, Kivelitz D, Gross W, Wagner A, Schulz-Menger J, et al. Behaviour of implantable coronary stents during magnetic resonance imaging. Int J Cardiovasc Intervent 1999; 2: 217-222.
12. 12. Shellock FG, Shellock VJ. Metallic stents: evaluation of MR imaging safety. AJR Am J Roentgenol 1999; 173: 543-547.
13. 13. Reinhardt J, Nguyen-Trong TH, Hähnel S, Bellemann ME, Heiland S Magnetic resonance imaging of stents: quantitative in vitro examination at 3 Tesla]. Z Med Phys 2009; 19: 278-287.
14. 14. Holton A, Walsh E, Anayiotos A, Pohost G, Venugopalan R. Comparative MRI compatibility of 316 L stainless steel alloy and nickel-titanium alloy stents. J Cardiovasc Magn Reson 2002; 4: 423-430.
15. 15. Strohm O, Kivelitz D, Gross W, Schulz-Menger J, Liu X, Hamm B, et al. Safety of implantable coronary stents during 1Hmagnetic resonance imaging at 1.0 and 1.5 T. J Cardiovasc Magn Reson 1999; 1: 239-245.
16. 16. Gerber TC, Fasseas P, Lennon RJ, Valeti VU, Wood CP, Breen JF, et al. Clinical safety of magnetic resonance imaging early after coronary artery stent placement. J Am Coll Cardiol 2003; 42: 1295-1298.
17. 17. Syed MA, Carlson K, Murphy M, Ingkanisorn WP, Rhoads KL, Arai AE. Long-term safety of cardiac magnetic resonance imaging performed in the first few days after bare-metal stent implantation. J Magn Reson Imaging 2006; 24: 1056-1061.
18. 18. Porto I, Selvanayagam J, Ashar V, Neubauer S, Banning AP. Safety of magnetic resonance imaging one to three days after bare metal and drug-eluting stent implantation. Am J Cardiol 2005; 96: 366-368.
19. 19. Rutledge JM, Vick GW 3rd, Mullins CE, Grifka RG. Safety of magnetic resonance imaging immediately following Palmaz stent implant: a report of three cases. Catheter Cardiovasc Interv 2001; 53: 519-523.
20. 20. Roubin GS, Robinson KA, King SB 3rd, Gianturco C, Black AJ, Brown JE, et al. Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs. Circulation 1987; 76: 891-897.
21. 21. MRI safety. Institute for Magnetic Resonance Safety, Education, and Research. Available from: http://www.MRIsafety.com. Accessed: June 19, 2010.
22. 22. Shellock FG, Forder JR. Drug eluting coronary stent: in vitro evaluation of magnet resonance safety at 3 Tesla. J Cardiovasc Magn Reson 2005; 7: 415-419.
23. 23. Shellock FG. MR safety at 3T: bare metal and drug eluting coronary artery stents. SIGNALS 2005; 53: 26-27.
24. 24. Shellock FG. Reference manual for magnetic resonance safety, implants, and devices: 2006 edition. Los Angeles, CA: Biomedical Research Publishing Group; 2006.
25. 25. Jehl J, Comte A, Aubry S, Meneveau N, Schiele F, Kastler B. Clinical safety of cardiac magnetic resonance imaging at 3 T early after stent placement for acute myocardial infarction. Eur Radiol 2009 Jul 9.
26. 26. Patel MR, Albert TS, Kandzari DE, Honeycutt EF, Shaw LK, Sketch MH Jr, Elliott MD, Judd RM, Kim RJ. Acute myocardial infarction: safety of cardiac MR imaging after percutaneous revascularization with stents. Radiology 2006 Sep; 240: 674-680.
27. 27. Shellock FG. Biomedical implants and devices: assessment of magnetic field interactions with a 3.0- Tesla MR system. J Magn Reson Imaging 2002;16:721-32.
28. 28. Engellau L, Olsrud J, Brockstedt S, Albrechtsson U, Norgren L, Stahlberg F, et al. MR evaluation ex vivo and in vivo of a covered stent-graft for abdominal aortic aneurysms: ferromagnetism, heating, artifacts, and velocity mapping. J Magn Reson Imaging 2000; 12: 112-121.
29. 29. Sommer T, Maintz D, Schmiedel A, Hackenbroch M, Hofer U, Urbach H, et al. High field MR imaging: magnetic field interactions of aneurysm clips, coronary artery stents and iliac artery stents with a 3.0 Tesla MR system. Rofo 2004; 176: 731- 8.
30. 30. Nehra A, Moran CJ, Cross DT 3rd, Derdeyn CP. MR safety and imaging of neuroform stents at 3T. AJNR Am J Neuroradiol 2004; 25: 1476-1478.
31. 31. van der Laan MJ, Bartels LW, Bakker CJ, Viergever MA, Blankensteijn JD. Suitability of 7 aortic stent-graft models for MRI-based surveillance. J Endovasc Ther 2004; 11: 366-371.
32. 32. Bonati LH, Jongen LM, Haller S, Flach HZ, Dobson J, Nederkoorn PJ, et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS; ICSS-MRI study group). Lancet Neurol 2010; 9: 353-362
33. 33. Macdonald S, Evans DH, Griffiths PD, McKevitt FM, Venables GS, Cleveland TJ, Gaines PA. Filter-protected versus unprotected carotid artery stenting: a randomised trial. Cerebrovasc Dis 2010; 29: 282-289.